Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

PONATINIB HYDROCHLORIDE

FDA · NDA · 2025-10-10

AgencyFDA
Submission typeNDA
Action date2025-10-10
BrandICLUSIG
SponsorTAKEDA PHARMS USA
RouteORAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T03:30:44.719Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:PONATINIB HYDROCHLORIDE:2025-10-10

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

PONATINIB HYDROCHLORIDE — approval | AEaH